CLVS Stock Rockets 20% as FDA Grants Priority Review to Rubraca
CLVS stock is trading sharply higher this morning after the FDA has accepted Clovis Oncology’s (NASDAQ:CLVS) supplemental marketing application seeking approval to use Rubraca (rucaparib). Major News In a new development that has come as ... [Read]
DARE Stock Soars 125% on Licensing Deal with Bayer
When a relatively small company signs a significant deal with one of the biggest companies in the world, then the former’s stock generally soars substantially. That is what happened with DARE stock this morning after ... [Read]
PHAS Stock Rockets 25% on Collaboration With SFJ Pharma
In a development that would come as a major boost to PHAS stock, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) announced that it has reached a major agreement with SFJ Pharmaceuticals. Important Collaboration The company announced today that ... [Read]
XERS Stock Jumps 12% Following Positive RTU Glucagon Data
When a pharmaceutical company announces positive results from any stage of a clinical study, then it almost always has a positive effect on the company’s stock. That is what happened with XERS stock in the ... [Read]
LPTX Stock Soars 60% After a Licensing Deal With BeiGene
Licensing agreements are generally great news for pharmaceutical companies, which is why such a development almost always proves to be a positive for the stock price. That is what happened with LPTX stock this morning ... [Read]
PULM Stock Skyrockets 86% on Licensing Deal With Johnson & Johnson
When a relatively small company ends up striking a deal with a giant corporation, then it generally proves to be a major boost for the stock. That is what has happened this morning with lightly ... [Read]
TCON Stock Jumps 15% After Collaborative Agreement for Envafolimab
The current week has seen a few important deals in the pharmaceutical world, and another one was announced this morning by TRACON Pharmaceuticals Inc (NASDAQ:TCON). Following the news, TCON stock soared over 18%. Big News ... [Read]
MIRM Stock Hits New High: Jumps 210% on Maralixibat Optimism
Meetings with the United States Food and Drug Administration are always key events for any pharmaceutical company, and it is especially so when it comes to a pre-New Drug Application (NDA). On Monday this week, ... [Read]
SGMO Stock Sinks After Making Gains on Gene Therapy Study
SGMO stock is trading down after Sangamo Therapeutics (NASDAQ:SGMO) made sizeable gains over the weekend following the release of positive results into a gene therapy hemophilia study. Strong Results California-based biotechnology firm Sangamo Therapeutics announced ... [Read]
AUPH Stock Hits Multi-Year High on Voclosporin’s Success
AUPH is the biggest biotech stock gainer on Thursday after Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) released highly positive results from the late-stage trial of its experimental product candidate voclosporin. Big News for Aurinia The product in ... [Read]